1-9 of 9
Sheh-Li Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Experience of Ropeginterferon-Alfa Treatment of PV and ET - Two Centers Experience

Tsewang Tashi, Brandi N. Reeves, Soo Jin Kim, Hyewon Jeong, Sheh-Li Chen, Brynn Parsegov, Josef T. Prchal
Journal: Blood
Blood (2023) 142 (Supplement 1): 6397.
https://doi.org/10.1182/blood-2023-191268
Published: 2023
Journal Articles

Ropegiterferon Alfa-2b-Njft for Treatment Myeloproliferative Neoplasms: A Single Institution Experience

Callie Berkowitz, Sheh-Li Chen, Brandi Reeves
Journal: Blood
Blood (2022) 140 (Supplement 1): 12254–12255.
https://doi.org/10.1182/blood-2022-164733
Published: 2022
Journal Articles

Rituximab Monotherapy Is Effective for Inhibitor Eradication with Concomitant Porcine Factor VIII Followed By Emicizumab for Bleed Control in Acquired Hemophilia a

Patrick Ellsworth, Sheh-Li Chen, Christopher Wang, Nigel S Key, Alice Ma
Journal: Blood
Blood (2021) 138 (Supplement 1): 348.
https://doi.org/10.1182/blood-2021-154207
Published: 2021
Journal Articles

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 792.
https://doi.org/10.1182/blood-2019-121340
Published: 2019
Journal Articles

Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Anqi Zhu, MS, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 390.
https://doi.org/10.1182/blood-2019-121343
Published: 2019
Journal Articles

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Nigel S. Key, MBChB, FRCP, Raj S. Kasthuri, MD, Micah J. Mooberry, MD, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2474.
https://doi.org/10.1182/blood-2018-99-118839
Published: 2018
Journal Articles

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1202.
https://doi.org/10.1182/blood-2018-99-119196
Published: 2018
Journal Articles

Importance of Pharmacokinetic Studies in the Management of Acquired Factor X Deficiency

Ming Yeong Lim, MBBChir, Timothy A. McCarthy, MD, Sheh-Li Chen, Pharm D, Alice D Ma, MD
Journal: Blood
Blood (2014) 124 (21): 5059.
https://doi.org/10.1182/blood.V124.21.5059.5059
Published: 2014
Journal Articles

Investigation Of a Cluster Of Inhibitors Among Previously Treated Hemophilia Patients (PTPs) At A Single Hospital In The United States

Nafisa Ghaji, MB BS MPH, Nigel S Key, MBChB, Connie H. Miller, PhD, Brenda Nielsen, MSN, RN, Tyler W. Buckner, MD, Sheh-Li Chen, Pharm D, W Craig Hooper, PhD, J. Michael Soucie, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1114.
https://doi.org/10.1182/blood.V122.21.1114.1114
Published: 2013